Proteomic profiling identifies markers for inflammation-related tumor-fibroblast interaction.
Daniel DrevAndrea BileckZeynep N ErdemThomas MohrGerald TimelthalerAndrea BeerChristopher GernerBrigitte MarianPublished in: Clinical proteomics (2017)
This study demonstrates the feasibility of detecting tumor- and compartment-specific protein-signatures that are functionally meaningful by proteomic profiling of whole-tissue extracts together with mining of RNA expression datasets. The results provide the basis for further exploration of inflammation-related stromal markers in larger patient cohorts and experimental models.